Braskem S.A. (BAK): A Bull Case Theory

We came across a bullish thesis on Braskem S.A. on Lasse’s Substack by Lasse. In this article, we will summarize the bulls’ thesis on BAK. Braskem S.A.’s share was trading at $3.2000 as of August 8th. BAK’s trailing and forward P/E were 8.44 and 9.78, respectively according to Yahoo Finance.

27 Largest Biotech Companies in the US

Pressmaster/Shutterstock.com

Braskem presents a compelling “cycle + overhang” investment opportunity at fire-sale levels, offering significant upside if polyolefin spreads mean-revert or if...